Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VEGF110 (AA 27-136) (Active) Protein

Origin: Human Host: HEK-293 Cells Recombinant >95 % as determined by SDS-PAGE. Func Active
Catalog No. ABIN4948990
  • Target
    VEGF110
    Protein Type
    Recombinant
    Biological Activity
    Active
    Protein Characteristics
    AA 27-136
    Origin
    Human
    Source
    • 1
    HEK-293 Cells
    Application
    Functional Studies (Func)
    Brand
    ActiveMax®
    Sequence
    AA 27-136
    Characteristics
    This protein carries no "tag". The protein has a calculated MW of 12.6 kDa. As a result of glycosylation, the protein migrates as 18-20 kDa under reducing (R) condition, and 40-45 kDa (homodimer) under non-reducing (NR) condition (SDS-PAGE).
    Purity
    >95 % as determined by SDS-PAGE.
    Endotoxin Level
    Less than 1.0 EU per μg by the LAL method.
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4
    Handling Advice
    Please avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
  • Target
    VEGF110
    Background
    Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, and is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. Alternatively spliced isoforms of 110,121,145,165,183,189 and 206 amino acids in length are expressed in humans.
    Molecular Weight
    12.7 kDa
    NCBI Accession
    NP_001165097
You are here:
Support